Equities

Cementos Bio Bio SA

CEMENTOS:SGO

Cementos Bio Bio SA

Actions
IndustrialsConstruction and Materials
  • Price (CLP)691.00
  • Today's Change0.00 / 0.00%
  • Shares traded5.39k
  • 1 Year change+4.70%
  • Beta0.1216
Data delayed at least 20 minutes, as of Nov 07 2024 15:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CLP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments14,18410,67642,165
Total Receivables, Net66,34155,11059,611
Total Inventory56,70058,94340,737
Prepaid expenses8,5378,2357,486
Other current assets, total176119644
Total current assets145,938133,082150,643
Property, plant & equipment, net293,921289,649289,974
Goodwill, net12,48512,48512,485
Intangibles, net6,0995,9145,699
Long term investments849912893
Note receivable - long term9,83412,05011,635
Other long term assets37412533
Total assets491,323475,747488,855
LIABILITIES
Accounts payable53,44655,19249,510
Accrued expenses11,09210,2039,740
Notes payable/short-term debt000
Current portion long-term debt/capital leases16,40714,32711,035
Other current liabilities, total18,59913,85410,969
Total current liabilities99,54493,57681,254
Total long term debt106,592108,517111,418
Total debt122,999122,844122,453
Deferred income tax20,91424,67832,822
Minority interest678666665
Other liabilities, total7,9597,3226,136
Total liabilities235,687234,759232,295
SHAREHOLDERS EQUITY
Common stock137,625137,625137,625
Additional paid-in capital------
Retained earnings (accumulated deficit)119,948103,993121,702
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(1937)(630)(2767)
Total equity255,636240,988256,560
Total liabilities & shareholders' equity491,323475,747488,855
Total common shares outstanding264264264
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.